FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula
and pharmaceutically acceptable salts thereof, where substitutes R1-R4 are as defined in claim 1. Said compounds have 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) enzyme inhibiting activity.
EFFECT: compounds can be used in form of a pharmaceutical composition.
15 cl, 1 tbl, 94 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMIDAZOLONE AND IMIDAZOLIDINONE DERIVATIVES AS 11B-HSD1 INHIBITORS FOR DIABETES | 2007 |
|
RU2439062C2 |
| PYRIDAZINE DERIVATIVES | 2006 |
|
RU2401832C2 |
| COMPOUNDS AND COMPOSITIONS AS CANNABINOID RECEPTOR 1 INHIBITORS | 2005 |
|
RU2431635C2 |
| COMPOUNDS THAT INHIBIT RELEASING INFLAMMATORY CYTOKINES | 2002 |
|
RU2278864C2 |
| CARBOXAMIDE COMPOUNDS AND USE THEREOF AS CALPAIN INHIBITORS | 2010 |
|
RU2567392C2 |
| SUBSTITUTED PYRAZOLOPYRIMIDINES AS GLUCOCEREBROSIDASE ACTIVATORS | 2011 |
|
RU2603637C2 |
| SUBSTITUTED PYRAZOLES | 2001 |
|
RU2286343C2 |
| DERIVATIVES OF 1,2,4-TRIAZOLE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2003 |
|
RU2319703C2 |
| SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIAL AGENTS | 2019 |
|
RU2797316C2 |
| CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS | 2010 |
|
RU2533122C2 |
